Dr. Sol Schulman is a hematology/oncology fellow at the Beth Israel Deaconess Medical Center and Harvard Medical School. After receiving B.S. and M.S. degrees in biochemistry from Brandeis University, he earned his M.D. and Ph.D. degrees through the joint Harvard/MIT Medical Scientist Training Program. Dr. Schulman performed his Ph.D. thesis research in the laboratory of Professor Tom Rapoport on human vitamin K metabolism and the mechanisms of warfarin resistance. He subsequently completed an internal medicine residency training at the Brigham and Women’s Hospital in Boston. Dr. Schulman is currently a research fellow under the mentorship of Dr. Bruce Furie. His JGP award project focuses on understanding the role of protein disulfide isomerase in prothrombin activation. Protein disulfide isomerase has been found to associate with prothrombin to stimulate clot formation. Therefore, it presents a novel strategy to acutely overcome bleeding in many assorted rare coagulation disorders that remain hard to treat.